Related Experiment Video
Updated: Jul 27, 2026
12:24
Computed Tomography-guided Time-domain Diffuse Fluorescence Tomography in Small Animals for Localization of Cancer Biomarkers
Published on: July 17, 2012
Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease
R L Albin1, S Minoshima, C J D'Amato
1Department of Neurology, University of Michigan, Ann Arbor, USA.
Neurology
|August 1, 1996
Summary
This study used fluoro-deoxyglucose positron emission tomography (FDG-PET) to examine brain metabolism in diffuse Lewy body disease (DLBD). Findings suggest FDG-PET can help differentiate DLBD from Alzheimer's disease (AD) antemortem.
Area of Science:
- Neurology
- Neuroimaging
- Pathology
Background:
- Diffuse Lewy body disease (DLBD) is a common neurodegenerative disorder.
- Distinguishing DLBD from Alzheimer's disease (AD) can be challenging using standard clinical methods.
- Cerebral hypometabolism patterns on FDG-PET may offer diagnostic clues.
Purpose of the Study:
- To investigate the cerebral metabolic patterns in pathologically verified DLBD using FDG-PET.
- To compare FDG-PET findings in pure DLBD with those in combined DLBD and AD pathology.
- To assess the potential of FDG-PET in differentiating DLBD from AD antemortem.
Main Methods:
- Six demented individuals with pathologically confirmed DLBD underwent FDG-PET scans.
- Three subjects had pure DLBD, and three had combined DLBD and AD pathology.
- Analysis focused on glucose metabolism across different brain regions.
Main Results:
- FDG-PET revealed diffuse cerebral hypometabolism in both DLBD and DLBD-AD groups.
- Hypometabolism was prominent in association cortices, with relative sparing of subcortical and primary somatomotor areas, similar to AD.
- Distinct from AD, DLBD cases showed hypometabolism in occipital association and primary visual cortices.
Conclusions:
- DLBD is characterized by diffuse cortical metabolic abnormalities.
- FDG-PET demonstrates distinct patterns that may aid in the antemortem differentiation of DLBD from AD.
- Occipital hypometabolism is a potential distinguishing feature of DLBD on FDG-PET.
Related Concept Videos
01:29Positron Emission Tomography
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
01:25Imaging Studies II: Positron Emission Tomography and Scintigraphy
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET